The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Pfizer (PFE) is the #14 analyst pick. Within the broader S&P 500, when components were ranked in terms of..
Daniel Garrahan highlights some of the big stories the FT is watching in the week ahead, including the second round of the French presidential elections; Pfizer, BP and Shell reporting first-quarter earnings; and the latest German jobs data.
According to Reuters, stocks on Wall Street fell for a third consecutive day.
Although morning losses were more severe, the top three markets on the New York Stock Exchange recovered slightly in the afternoon.
The Nasdaq Composite led losses,..
In early trading on Thursday, shares of Pfizer (PFE) topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.5%. Year to date, Pfizer has lost about 0.1% of its value.
According to a report by Reuters, United States lawmakers called drug pricing practices 'morally repugnant' and told pharmaceutical executives they don't to hear them blame others for high prices, at a Senate hearing on the rising costs of..
According to Reuters, U.S. Senators called drug pricing practices “morally repugnant” and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at the start of a Senate hearing on..
According to Business Insider, the leaders of seven major pharmaceutical companies are testifying before Congress about high US drug prices on Tuesday. The group of executives are attempting to justify their company's exorbitant prices in the..
In early trading on Friday, shares of Intel Corp (INTC) topped the list of the day's best performing Dow Jones Industrial Average components, trading up 2.1%. Year to date, Intel Corp registers a 11.9% gain.
NEW YORK (Reuters) - Wall Street languished near the starting gate in mid-afternoon trading on Monday as investor hopes over U.S.-China trade talks were muted by concerns about possible congressional gridlock and a diminished 2019 earnings outlook...
Pfizer confirmed its interest in a takeover of the UK pharmaceuticals group, in what would be one of the biggest deals in the industry's history. Lex's Oliver Ralph and Robert Armstrong discuss the latest developments.
For more video content from..
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Josh de la Mare provides Tuesday’s top stories, with Pfizer seeking support from Washington for its $160bn Allergan deal, Turkey shooting down a Russian jet near the Syrian..